Gordon Brandt, Executive VP of Science and Clinica at NASTECH PHARMACEUTICAL CO INC (NSTK), sold 5,000 shares at $16.45 ($82K) on 2006-11-03, disclosed to the SEC on 2006-11-03.
Scheduled sale ($82k) by Executive VP of Science and Clinica under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| NSTK | SELL | 2007-01-05 | $73K | — | Filing → |
| NSTK | SELL | 2006-12-22 | $11K | — | Filing → |
| NSTK | SELL | 2006-12-07 | $81K | — | Filing → |